Melanoma
Lymph Node Dissection/Observation for Localized Melanoma (7108)
Multicenter Selective Lymphadenectomy for Melanoma Trial II: A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients with Molecular or Histopathological Evidence of Metastases in the Sentinel Node [Randomization phase]
Investigator: David Byrd, MD; Conditions: Melanoma; Status: Recruiting; Study ID: NCT00389571
Randomized, Phase II Study of MK-3475 Versus Chemotherapy in Patients With Advanced Melanoma
Investigator: Kim Margolin, M.D.; Conditions: Malignant Melanoma; Status: Recruiting; Study ID: NCT01704287
The High-Dose Aldesleukin (IL-2) "SELECT" Trial: A Prospective Tissue Collection Protocol to Investigate Predictive Models of Response to High-Dose IL-2 Treatments in Patients With Advance Melanoma
Investigator: Kim Margolin, MD; Conditions: Malignant Melanoma; Status: Recruiting; Study ID: NCT01288963
Phase I/II Study of Cellular Adoptive Immunotherapy Using Autologous CD8+ NY-ESO-1-Specific T Cell Clones and Anti-CTLA4 for Patients With Metastatic Melanoma
Investigator: Aude Chapuis, MD; Conditions: Melanoma (Skin); Status: Recruiting; Study ID: NCT00871481
A Phase I Dose Escalation Study of BMS-982470 (Recombinant Interleukin 21, rIL-21) in Combination With Ipilimumab in Subjects With Unresectable Stage III or Stage IV Melanoma
Investigator: Shailender Bhatia, M.D.; Conditions: Melanoma; Status: Recruiting; Study ID: NCT01489059
An Exploratory Study of the Biologic Effects of BMS-936558 (Anti-PD-1 Monoclonal Antibody) Treatment in Subjects With Advanced Melanoma (Unresectable or Metastatic)
Investigator: Shailender Bhatia, M.D.; Conditions: Advanced Melanoma, Metastatic Melanoma; Status: Recruiting; Study ID: NCT01621490
A Phase I, Open-Label, Dose Escalation Study of MLN4924, a Novel Inhibitor of Nedd8-Activating Enzyme, in Adult Patients With Melanoma
Investigator: Dr. Shailender Bhatia; Conditions: Metastatic Melanoma; Status: Closed/Not Recruiting; Study ID: NCT01011530
Join Us On